Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Revisiting the ancient concept of botanical therapeutics

Mixtures of interacting compounds produced by plants may provide important combination therapies that simultaneously affect multiple pharmacological targets and provide clinical efficacy beyond the reach of single compound–based drugs. Developing innovative scientific methods for discovery, validation, characterization and standardization of these multicomponent botanical therapeutics is essential to their acceptance into mainstream medicine.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: Thundergod vine and its natural products.
Figure 3: A. dracunculus is being grown under strict environmental conditions for the production of medically active compounds being tested for antidiabetic activity.
Figure 4: Flowchart depicting the development paths for different categories of MCBTs in the United States.

References

  1. Koehn, F.E. & Carter, G.T. Nat. Rev. Drug Discov. 4, 206–220 (2005).

    Article  CAS  Google Scholar 

  2. Newman, D.J. & Cragg, G.M. J. Nat. Prod. 70, 461–477 (2007).

    Article  CAS  Google Scholar 

  3. Farnsworth, N.R. & Morris, R.W. Am. J. Pharm. Sci. Support. Public Health 148, 46–52 (1976).

    CAS  PubMed  Google Scholar 

  4. Raskin, I. & Ripoll, C. Curr. Pharm. Des. 10, 3419–3429 (2004).

    Article  CAS  Google Scholar 

  5. Raskin, I. et al. Trends Biotechnol. 20, 522–531 (2002).

    Article  CAS  Google Scholar 

  6. Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach (John Wiley & Sons, West Sussex, England, 2002).

    Google Scholar 

  7. Cragg, G.M. Med. Res. Rev. 18, 315–331 (1998).

    Article  CAS  Google Scholar 

  8. Abdin, M.Z., Israr, M., Rehman, R.U. & Jain, S.K. Planta Med. 69, 289–299 (2003).

    Article  CAS  Google Scholar 

  9. Goldbach-Mansky, R. et al. in American College of Rheumatology Proceedings of 2006 Annual Meeting, Washington, DC, November 10–15, 2006 (ed. Lockshin, M.D.) (Tri-Star Publishing, Inc., Overland Park, Kansas, USA, 2006).

    Google Scholar 

  10. Kupchan, S.M. et al. J. Am. Chem. Soc. 94, 7194–7195 (1972).

    Article  CAS  Google Scholar 

  11. Demmig-Adams, B. & Adams, W.W., III . Science 298, 2149–2153 (2002).

    Article  CAS  Google Scholar 

  12. Butler, M.S. J. Nat. Prod. 67, 2141–2153 (2004).

    Article  CAS  Google Scholar 

  13. Sams-Dodd, F. Drug Discov. Today 11, 465–472 (2006).

    Article  CAS  Google Scholar 

  14. Agrawal, L., Lu, X., Jin, Q. & Alkhatib, G. Curr. Pharm. Des. 12, 2031–2055 (2006).

    Article  CAS  Google Scholar 

  15. Blomberg, B. & Fourie, B. Drugs 63, 535–553 (2003).

    Article  CAS  Google Scholar 

  16. Schellenberg, D., Abdulla, S. & Roper, C. Curr. Mol. Med. 6, 253–260 (2006).

    Article  CAS  Google Scholar 

  17. Waterhouse, D.N. et al. Curr. Cancer Drug Targets 6, 455–489 (2006).

    Article  CAS  Google Scholar 

  18. Deedwania, P.C. & Volkova, N. Curr. Treat. Options Cardiovasc. Med. 7, 61–74 (2005).

    Article  Google Scholar 

  19. HemaIswarya . Phytother. Res. 20, 239–249 (2006).

    Article  CAS  Google Scholar 

  20. Ahmad, I. & Aqil, F. Microbiol. Res. (in the press).

  21. Aqil, F., Ahmad, I. & Owais, M. Biotechnol. J. 1, 1093–1102 (2006).

    Article  CAS  Google Scholar 

  22. Ribnicky, D.M. et al. Phytomedicine 13, 550–557 (2006).

    Article  CAS  Google Scholar 

  23. Burdock, G.A., Carabin, I.G. & Griffiths, J.C. Toxicology 221, 17–27 (2006).

    Article  CAS  Google Scholar 

  24. Koch, M.A. et al. Proc. Natl. Acad. Sci. USA 102, 17272–17277 (2005).

    Article  CAS  Google Scholar 

  25. Ong, E.S. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 812, 23–33 (2004).

    Article  CAS  Google Scholar 

  26. Coppens, P., da Silva, M.F. & Pettman, S. Toxicology 221, 59–74 (2006).

    Article  CAS  Google Scholar 

  27. Nichols, A. Methods Mol. Biol. 356, 379–387 (2007).

    CAS  PubMed  Google Scholar 

  28. Spira, B. Curr. Pharm. Anal. 1, 243–249 (2005).

    Article  CAS  Google Scholar 

  29. Murphey, R.D. & Zon, L.I. Methods 39, 255–261 (2006).

    Article  CAS  Google Scholar 

  30. Bindseil, K.U. et al. Drug Discov. Today 6, 840–847 (2001).

    Article  CAS  Google Scholar 

  31. Cragg, G.M. & Newman, D.J. J. Ethnopharmacol. 100, 72–79 (2005).

    Article  CAS  Google Scholar 

  32. Gusman, J. & Vanhaelen, M. Recent Res. Dev. Phytochem. 4, 187–206 (2000).

    CAS  Google Scholar 

  33. Brinker, A.M., Ma, J., Lipsky, P.E. & Raskin, I. Phytochemistry 68, 732–766 (2007).

    Article  CAS  Google Scholar 

  34. Tao, X. et al. Arthritis Rheum. 46, 1735–1743 (2002).

    Article  Google Scholar 

  35. Wang, Z.Q. et al. in 64th Scientific Sessions of the American Diabetes Association, Orlando, Florida, USA, June 4–8, 2004 (ed. Matschinsky, F.M.) (American Diabetes Association, Alexandria, Virginia, USA, 2004).

    Google Scholar 

  36. Wang, Z.Q. et al. in 66th Scientific Sessions of the American Diabetes Association, Washington, DC, June 9–13, 2006 (ed. Matschinsky, F.M.) (American Diabetes Association, Alexandria, Virginia, USA, 2006).

    Google Scholar 

  37. Logendra, S. et al. Phytochemistry 67, 1539–1546 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. von Roy, B. Fridlender and T. Sox for critical review of this paper. Research supported by Phytomedics Inc.; National Institutes of Health (NIH) Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome, grant no. 1-P50 AT002776-01; Fogarty International Center of the NIH under U01 TW006674 for the International Cooperative Biodiversity Groups; and Rutgers University.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

I.R. has a financial interest in Phytomedics, Inc., a biopharmaceutical company, which partially supports research in I.R.'s laboratory.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, B., Ribnicky, D., Lipsky, P. et al. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3, 360–366 (2007). https://doi.org/10.1038/nchembio0707-360

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio0707-360

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing